HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pituitary apoplexy in an acromegalic patient during bromocriptine therapy. Case report.

Abstract
The authors report a case of pituitary apoplexy that developed in a patient shortly after bromocriptine therapy was started for a growth hormone-secreting pituitary adenoma. The tumor was associated with visual impairment and ocular palsies, and was treated by transsphenoidal decompression. Although spontaneous tumor necrosis cannot be excluded, a causal role of bromocriptine treatment is suggested.
AuthorsA Alhajje, M Lambert, J Crabbé
JournalJournal of neurosurgery (J Neurosurg) Vol. 63 Issue 2 Pg. 288-92 (Aug 1985) ISSN: 0022-3085 [Print] United States
PMID4020451 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bromocriptine
  • Growth Hormone
Topics
  • Adenoma (diagnostic imaging, drug therapy, metabolism, physiopathology)
  • Bromocriptine (adverse effects, therapeutic use)
  • Cerebrovascular Disorders (chemically induced)
  • Endocrine Glands (physiopathology)
  • Female
  • Growth Hormone (metabolism)
  • Humans
  • Middle Aged
  • Pituitary Gland (blood supply)
  • Pituitary Neoplasms (diagnostic imaging, drug therapy, metabolism, physiopathology)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: